Instrumento Inactivo

Publs. oficiales THERACLION N Euronext Paris

Acciones

Precio de cierre Euronext Paris Otros sitios de cotización
- ^EUR	-

27/03	Theraclion SA presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
2023	Theraclion logra un hito importante en su camino hacia el mercado estadounidense: Primeros pacientes tratados con Sonovein como parte del estudio pivotal aprobado por la FDA	CI

Combined general shareholders meeting	13/05	CO
Financial report	25/04	CO
Annual results	27/03	CO
Annual results	27/03	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	01/02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	30/01	CO
4th quarter turnover	29/01	CO
4th quarter turnover	29/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	31/10/23	CO
Half-year report	30/10/23	CO
1st-half-year results	11/10/23	CO
1st-half-year results	11/10/23	CO
Monthly statement on voting rights	30/09/23	CO
Monthly statement on voting rights	31/08/23	CO
Monthly statement on voting rights	31/07/23	CO
Minutes of the general assembly	29/06/23	CO
Admission of new securities	22/06/23	CO
Admission of new securities	22/06/23	CO
Mixed general Shareholders meeting notice	14/06/23	CO
Monthly statement on voting rights	31/05/23	CO
Changes in management and corporate officers	25/05/23	CO
Changes in management and corporate officers	25/05/23	CO
Combined general shareholders meeting	24/05/23	CO